Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.67 |
| ▸ | CA2 | P00918 | 8/20 | 0.67 |
| ▸ | CA9 | Q16790 | 6/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | HSPB1 | P04792 | 2/20 | 0.53 |
| ▸ | CA12 | O43570 | 5/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.48 |
| ▸ | CA3 | P07451 | 2/20 | 0.48 |
| ▸ | CA4 | P22748 | 2/20 | 0.48 |
| ▸ | CA6 | P23280 | 2/20 | 0.48 |
| ▸ | CA5A | P35218 | 2/20 | 0.48 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL866410 | 0.83 | CA1 (0.71) | CA1CA2CA9HTTHSPB1 | |
| SCHEMBL7527679 | 0.81 | CA1 (0.62) | CA1CA2CA9HTTHSPB1 | |
| SCHEMBL866411 | 0.80 | CA1 (0.67) | CA1CA2CA9HTTHSPB1 | |
| SCHEMBL3519559 | 0.80 | CA2 (1.00) | CA1CA2CA9HTTCA12 | |
| SCHEMBL31634023 | 0.80 | CA1 (0.67) | CA1CA2CA9HTTHSPB1 | |
| SCHEMBL8690274 | 0.80 | CA1 (0.67) | CA1CA2CA9HTTHSPB1 | |
| SCHEMBL11704991 | 0.80 | CA1 (0.67) | CA1CA2CA9HTTHSPB1 | |
| Potassium Ion SCHEMBL1902294 | 0.80 | CA1 (0.67) | CA1CA2CA9HTTHSPB1 | |
| SCHEMBL17318171 | 0.80 | CA1 (0.67) | CA1CA2CA9HTTHSPB1 | |
| Sulfuric Acid SCHEMBL3198737 | 0.78 | CA1 (0.65) | CA1CA2CA9HTTHSPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747231-A1 | LIPIDS AND LIPID NANOPARTICLES | Geneditbio Limited (HK) | 2026-05-27 | — | — | EP | disclosed |
| EP-4211146-B1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | UNIV BAR ILAN (IL) | 2026-05-20 | — | — | EP | disclosed |
| US-12616760-B2 | Synthetic cyclic peptide mimetics | BAR ILAN UNIVERSITY (IL) | 2026-05-05 | — | — | US | disclosed |
| EP-4725941-A1 | ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2026-04-15 | — | — | EP | disclosed |
| EP-4702010-A1 | PHOTOACTIVE COMPOUNDS | Merck Patent GmbH (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-20250262298-A1 | STING MODULATOR COMPOUNDS WITH SULFAMATE LINKAGES, AND METHODS OF MAKING AND USING | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2025-08-21 | — | — | US | disclosed |
| CN-114751950-B | Cyclic dinucleotide compounds and methods of use | 免疫传感器公司 | 2025-04-18 | — | — | CN | disclosed |
| WO-2025016446-A1 | LIPIDS AND LIPID NANOPARTICLES | GENEDITBIO LIMITED (CN) | 2025-01-23 | — | — | WO | disclosed |
| CN-115803024-B | Compositions comprising aryl amide derivatives | 中外制药株式会社 | 2025-01-10 | — | — | CN | disclosed |
| CN-114929669-B | Aryl amide derivatives with antitumor activity | 中外制药株式会社 | 2024-11-29 | — | — | CN | disclosed |
| US-5086128-A | HIGH MOLECULAR WEIGHT ARYLENE SULPHIDE POLYMER MELT MIXED WITH AROMATIC NITRO COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1992-02-04 | — | — | US | disclosed |
| EP-0309912-B1 | Process for the preparation of alkylated dodecahydro-naphtho[2,1-B]furans | BASF Aktiengesellschaft (DE) | 1991-05-15 | — | — | EP | disclosed |
| EP-0370953-A2 | Process for the preparation of dye intermediates | CIBA-GEIGY AG (CH) | 1990-05-30 | — | — | EP | disclosed |
| EP-0309912-A1 | Process for the preparation of alkylated dodecahydro-naphtho[2,1-B]furans | BASF Aktiengesellschaft (DE) | 1989-04-05 | — | — | EP | disclosed |
| US-4388246-A | THERMAL SPLITTING OF CARBAMATES | BAYER AKTIENGESELLSCHAFT (DE) | 1983-06-14 | — | — | US | disclosed |
| US-4379784-A | ANTIBIOTICS | DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1983-04-12 | — | — | US | disclosed |
| EP-0010249-A2 | Herbicidal agents, process for their preparation and their use in combating weeds | BAYER AG (DE) | 1980-04-30 | — | — | EP | disclosed |
| EP-0010250-A2 | Use of Sulfonanilides in inhibition of plant growth | BAYER AG (DE) | 1980-04-30 | — | — | EP | disclosed |
| US-4150223-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1979-04-17 | — | — | US | disclosed |
| US-4032521-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1977-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616760-B2 | Synthetic cyclic peptide mimetics | TPX2, IAPP, HAX1 | CA1 208/4885CA2 2097/4885CA9 792/4885 |
| US-20250262298-A1 | STING MODULATOR COMPOUNDS WITH SULFAMATE LINKAGES, AND METHODS OF MAKING AND USING | STING1, CGAS, TBK1 | CA1 4276/4885CA2 2144/4885CA9 3393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.